Fleming v. Impax Laboratories Inc., et al.
Impax Securities Settlement
Case No. 4:16-cv-06557-HSG (N.D. Cal.)

Welcome to the Impax Securities Litigation Website

PLEASE NOTE: The Class Action Settlement has been Approved by the Court on July 15, 2022. Final Judgment has been entered by the Court on July 21, 2022.

The information contained on this website is only a summary of the information presented in more detail in the Notice of Pendency and Proposed Settlement of Class Action. Because this website is just a summary, you should review the Notice for additional details.

Summary of the Action

The Notice relates to the approved Settlement of a class action lawsuit pending against the following defendants: Impax, George Frederick Wilkinson, Dr. Larry Hsu, Dr. Carole Ben-Maimon, and Bryan M. Reasons. The approved Settlement, will apply to the following Class: all Persons that purchased or acquired Impax common stock or 2% Convertible Senior Notes during the Class Period.  Excluded from the Class are: (i) Defendants; (ii) members of the immediate families of the Individual Defendants; (iii) Impax’s subsidiaries; (iv) the officers and directors of Impax during the Class Period; (v) any entity in which any Defendant has a controlling interest; and (vi) the legal representatives, heirs, successors and assigns of any such excluded person or entity.  Also excluded from the Class will be any Person who timely and validly seeks exclusion from the Class.  Anyone with questions as to whether or not they are excluded from the Class may call the Claims Administrator toll-free at 1-833-823-0051.

Following Court approval, and as described more fully in paragraphs 44-50 in the Notice, Plaintiffs, on behalf of the Class, have agreed to settle all Released Claims (as defined in paragraph 45 in the Notice) against Defendants and other Released Defendant Parties (as defined in paragraph 47 in the Notice) in exchange for a settlement payment of $33 million in cash to be deposited into an escrow account.  The Net Settlement Fund will be distributed in accordance with the Court-approved plan of allocation and will determine how the Net Settlement Fund shall be distributed to members of the Class. The objective of the Plan of Allocation is to equitably distribute the Net Settlement Fund to those Class Members who suffered economic losses as a proximate result of the alleged wrongdoing. The Court-approved Plan of Allocation is included in the Notice.

The Class is defined as:

All Persons that purchased or acquired Impax common stock or 2% Convertible Senior Notes between February 20, 2014 and August 9, 2016, inclusive

Payments to eligible claimants will be made only after the completion of all claims processing. Please be patient, as this process will take some time to complete.

YOUR LEGAL RIGHTS AND OPTIONS IN THE SETTLEMENT:
DO NOTHING Get no payment.  Remain a Class Member.  Give up your rights.
REMAIN A MEMBER OF THE CLASS AND SUBMIT A CLAIM FORM POSTMARKED NO LATER THAN MARCH 21, 2022 This is the only way to be potentially eligible to receive a payment.  If you wish to obtain a payment as a member of the Class, you will need to file a claim form (the “Claim Form” or “Proof of Claim Form”), which is included with the Notice, postmarked no later than March 21, 2022. This deadline has passed.

 

How do I obtain more information?

Detailed information about the Settlement is contained in the Notice available for download on the Important Documents page on this website. Additional information can also be obtained by contacting the Claims Administrator by calling toll-free 1-833-823-0051 or emailing info@ImpaxSecuritiesSettlement.com or mailing a letter to:

Impax Securities Settlement
c/o JND Legal Administration
P.O. Box 91417
Seattle, WA 98111

Inquiries should NOT be directed to the Court or the Clerk of the Court.

 

For More Information

Visit this website often to get the most up-to-date information.

Mail
Impax Securities Settlement
c/o JND Legal Administration
PO Box 91417
Seattle, WA 98111